Epirus Biopharmaceuticals Inc Stock Other OTC
Equities
US29428P1075
Biotechnology & Medical Research
Financials (USD)
Sales 2014 | 0 | Sales 2015 | 0.7 | Capitalization | 75.33M |
---|---|---|---|---|---|
Net income 2014 | -41M | Net income 2015 | -52M | EV / Sales 2014 | 14,770,294,750 x |
Net cash position 2014 | 14.18M | Net cash position 2015 | 16.68M | EV / Sales 2015 | 83,658,631 x |
P/E ratio 2014 |
-0.83
x | P/E ratio 2015 |
-1.35
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+0.78% | 42.59B | |
+6.16% | 40.65B | |
+47.75% | 40.57B | |
-11.96% | 26.77B | |
+7.49% | 24.81B | |
-25.00% | 18.17B | |
+27.79% | 12.05B | |
-3.81% | 11.7B | |
+7.32% | 11.1B |